Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Philippe CourtetCHRU Montpellier, Inserm U888, University of Montpellier I, Montpellier, FranceAbstract: Suicidal behavior (SB) represents a major public health issue. Clinical and basic research suggests that SB is a specific entity in psychiatric nosology involving a combination of personality tra...
Guardado en:
Autor principal: | Philippe Courtet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25d036764cf1441f912c588d42e6a147 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants – a case series
por: Kirino E, et al.
Publicado: (2011) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Alla Avedisova, et al.
Publicado: (2009) -
Antidepressant therapy with milnacipran and venlafaxine
por: Lucilla Mansuy
Publicado: (2010) -
Milnacipran: a unique antidepressant?
por: Siegfried Kasper, et al.
Publicado: (2010) -
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Maurizio Pompili, et al.
Publicado: (2008)